UNLABELLED: TNF has diverse biological effects including a role in the immune response and growth regulatory effects. OBJECTIVES: The aim of this study was to determine the nature and location of cells able to synthesise and respond to TNF in oral mucosa in health and disease. MATERIALS AND METHODS: The location of immunoreactive TNF and 55-kDa and 75-kDa TNF receptors was demonstrated using immunohistology. We also used RT-PCR to help determine the sites of synthesis of this cytokine in oral mucosa. RESULTS: Only occasional TNF-positive cells were detected in normal epidermis and oral mucosa. However, this cytokine was found throughout the epithelia in oral lichen planus, leukoplakia and squamous cell carcinoma (SCC). The possible cellular sources and biological effects of TNF in these disease processes is discussed. The 55-kDa TNFR was expressed at the cell membrane throughout the epidermis, but confined to the lower cell layers on oral mucosa. Ten of 22 SCC did not express this receptor. A significant correlation was observed between the velocity of tumour growth and absence of TNF receptors. CONCLUSIONS: The growth inhibitory and immunoregulatory effects of TNF may be modulated by changes in receptor expression and alterations in synthesis of this cytokine in a subgroup of oral SCC.
UNLABELLED: TNF has diverse biological effects including a role in the immune response and growth regulatory effects. OBJECTIVES: The aim of this study was to determine the nature and location of cells able to synthesise and respond to TNF in oral mucosa in health and disease. MATERIALS AND METHODS: The location of immunoreactive TNF and 55-kDa and 75-kDa TNF receptors was demonstrated using immunohistology. We also used RT-PCR to help determine the sites of synthesis of this cytokine in oral mucosa. RESULTS: Only occasional TNF-positive cells were detected in normal epidermis and oral mucosa. However, this cytokine was found throughout the epithelia in oral lichen planus, leukoplakia and squamous cell carcinoma (SCC). The possible cellular sources and biological effects of TNF in these disease processes is discussed. The 55-kDa TNFR was expressed at the cell membrane throughout the epidermis, but confined to the lower cell layers on oral mucosa. Ten of 22 SCC did not express this receptor. A significant correlation was observed between the velocity of tumour growth and absence of TNF receptors. CONCLUSIONS: The growth inhibitory and immunoregulatory effects of TNF may be modulated by changes in receptor expression and alterations in synthesis of this cytokine in a subgroup of oral SCC.
Authors: Hai Lu; Xinping Yang; Praveen Duggal; Clint T Allen; Bin Yan; Jonah Cohen; Liesl Nottingham; Rose-Anne Romano; Satrajit Sinha; Kathryn E King; Wendy C Weinberg; Zhong Chen; Carter Van Waes Journal: Cancer Res Date: 2011-09-20 Impact factor: 12.701
Authors: S Perrier; B Kherratia; C Deschaumes; S Ughetto; J-L Kemeny; M Baudet-Pommel; B Sauvezie Journal: Clin Exp Immunol Date: 2002-01 Impact factor: 4.330
Authors: D C Duffey; C V Crowl-Bancroft; Z Chen; F G Ondrey; M Nejad-Sattari; G Dong; C Van Waes Journal: Br J Cancer Date: 2000-11 Impact factor: 7.640
Authors: Nicolae-Costin Diaconu; Jaana Rummukainen; Mikko Mättö; Anita Naukkarinen; Rauno J Harvima; Jukka Pelkonen; Ilkka T Harvima Journal: BMC Cancer Date: 2008-02-07 Impact factor: 4.430
Authors: L K Nottingham; C H Yan; X Yang; H Si; J Coupar; Y Bian; T-F Cheng; C Allen; P Arun; D Gius; L Dang; C Van Waes; Z Chen Journal: Oncogene Date: 2013-03-04 Impact factor: 9.867